Average Length Of Stay clinical trials

Explore recruiting average length of stay clinical trials.

Recruiting average length of stay studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Average Length Of Stay trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study

France, Italy, Greece, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Average Length Of Stay trials by city

Average Length Of Stay in Toronto Average Length Of Stay in Vancouver Average Length Of Stay in Montreal Average Length Of Stay in Calgary Average Length Of Stay in Edmonton Average Length Of Stay in Ottawa Average Length Of Stay in Winnipeg Average Length Of Stay in Quebec City Average Length Of Stay in Hamilton Average Length Of Stay in Kitchener Average Length Of Stay in London Average Length Of Stay in Halifax Average Length Of Stay in New York Average Length Of Stay in Los Angeles Average Length Of Stay in Chicago Average Length Of Stay in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease